Lateral Flow Assay Market by Application (Clinical Testing (Pregnancy, Infectious Disease (Mosquito , Influenza, STI, Hepatitis, TB), Cardiac Marker, Lipid Test) Veterinary, Food Safety) Product (Reader, Kits) Technique, End User - Global Forecast to 2023

Table of Contents

1.... INTRODUCTION

1.1            OBJECTIVES OF THE STUDY
1.2            MARKET DEFINITION
1.3            MARKET SCOPE
1.3.1             MARKETS COVERED.. 27
1.3.2             YEARS CONSIDERED FOR THE STUDY
1.4            CURRENCY
1.5            LIMITATIONS
1.6            STAKEHOLDERS

2.... RESEARCH METHODOLOGY

2.1            RESEARCH DATA
2.1.1             SECONDARY DATA
2.1.1.1           KEY DATA FROM SECONDARY SOURCES
2.1.2             PRIMARY DATA
2.1.2.1           KEY DATA FROM PRIMARY SOURCES
2.1.2.2           KEY INDUSTRY INSIGHTS
2.2            MARKET SIZE ESTIMATION
2.2.1             BOTTOM-UP APPROACH
2.2.2             TOP-DOWN APPROACH. 38
2.3            MARKET BREAKDOWN & DATA TRIANGULATION
2.4            MARKET SHARE ESTIMATION
2.5            ASSUMPTIONS FOR THE STUDY

3.... EXECUTIVE SUMMARY

4.... PREMIUM INSIGHTS

4.1            LATERAL FLOW ASSAYS: MARKET OVERVIEW
4.2            LATERAL FLOW ASSAYS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES/REGION
4.3            LATERAL FLOW ASSAYS MARKET: MAJOR COUNTRIES
4.4            GEOGRAPHIC MIX: LATERAL FLOW ASSAYS MARKET
4.5            LATERAL FLOW ASSAYS MARKET IN ASIA PACIFIC,  BY APPLICATION AND COUNTRIES

5.... MARKET OVERVIEW

5.1            INTRODUCTION
5.2            MARKET DYNAMICS: IMPACT ANALYSIS
5.2.1             MARKET DRIVERS
5.2.1.1           HIGH PREVALENCE OF INFECTIOUS DISEASES ACROSS THE GLOBE
5.2.1.2           RAPIDLY INCREASING GERIATRIC POPULATION
5.2.1.3           GROWING USAGE OF HOME-BASED LATERAL FLOW ASSAY DEVICES
5.2.1.4           GROWING DEMAND FOR POINT-OF-CARE TESTING
5.2.2             MARKET RESTRAINTS. 55
5.2.2.1           RELUCTANCE TOWARDS CHANGING EXISTING DIAGNOSTIC PRACTICES
5.2.2.2           IMPLEMENTATION OF EXCISE DUTY ON MEDICAL DEVICES IN THE US
5.2.3             MARKET OPPORTUNITIES
5.2.3.1           EVOLVING APPLICATIONS OF LATERAL FLOW ASSAYS
5.2.3.2           RISING DEMAND FOR LATERAL FLOW ASSAYS IN THE FOOD & BEVERAGE INDUSTRY
5.2.4             CHALLENGES
5.2.4.1           LIMITED REIMBURSEMENTS FOR LATERAL FLOW ASSAY PRODUCTS

6.... INDUSTRY INSIGHTS

6.1            INTRODUCTION
6.2            INDUSTRY TRENDS
6.2.1             INTEGRATION OF MICROFLUIDIC TECHNOLOGY  IN LATERAL FLOW ASSAYS
6.2.2             DEMAND FOR QUANTITATIVE RESULTS
6.2.3             RISING DEMAND FOR MULTIPLEXED LATERAL FLOW BIOSENSORS
6.3            VALUE CHAIN ANALYSIS
6.4            SUPPLY CHAIN ANALYSIS
6.5            REGULATORY ANALYSIS
6.5.1             NORTH AMERICA
6.5.2             EUROPE
6.5.3             ASIA
6.5.3.1           INDIA
6.5.3.2           CHINA
6.5.3.3           JAPAN
6.6            PARENT MARKETS ANALYSIS

7.... LATERAL FLOW ASSAYS MARKET, BY PRODUCT

7.1            INTRODUCTION
7.2            KITS & REAGENTS
7.2.1             INCREASING DEMAND FOR POC TESTING IS DRIVING THE DEMAND FOR KITS AND REAGENTS IN THE LATERAL FLOW ASSAYS MARKET
7.3            LATERAL FLOW READERS
7.3.1             DIGITAL/MOBILE READERS
7.3.1.1           GROWING AWARENESS, TECHNOLOGICAL ADVANCEMENTS, AND HIGH ACCURACY ARE MAJOR FACTORS DRIVING THE GROWTH OF THE DIGITAL/MOBILE READERS MARKET. 74
7.3.2             BENCHTOP READERS. 76
7.3.2.1           LOWER DIAGNOSIS COST PER PATIENT IS DRIVING THE BENCHTOP READERS MARKET

8.... LATERAL FLOW ASSAYS MARKET, BY APPLICATION

8.1            INTRODUCTION
8.2            CLINICAL TESTING
8.2.1             INFECTIOUS DISEASE TESTING
8.2.1.1           MOSQUITO-BORNE DISEASE TESTING
8.2.1.1.1           INCREASING INCIDENCE OF DENGUE DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY MARKET FOR MOSQUITO-BORNE TESTING
8.2.1.2           INFLUENZA TESTING
8.2.1.2.1           GROWING PREVALENCE OF INFLUENZA IS EXPECTED TO DRIVE THE INFLUENZA TESTING MARKET.
8.2.1.3           SEXUALLY TRANSMITTED INFECTION TESTING
8.2.1.3.1           HIV TESTING
8.2.1.3.1.1        GROWING AWARENESS ABOUT HIV POC TESTING ARE THE MAJOR FACTORS DRIVING MARKET GROWTH.
8.2.1.3.2           HPV TESTING
8.2.1.3.2.1        RISING ADOPTION OF HPV TESTING IS EXPECTED TO DRIVE THE MARKET DURING FORECAST PERIOD
8.2.1.3.3           CHLAMYDIA TESTING
8.2.1.3.3.1        CONSISTANTLY GROWING INCIDENCE OF CHLAMYDIA AND RISING AWARENESS AMONG PATIENTS IS DRIVING THIS MARKET
8.2.1.3.4           GONORRHEA TESTING
8.2.1.3.4.1        THE RISING INCIDENCE OF GONORRHEA GLOBALLY IS EXPECTED TO DRIVE THE LATERAL FLOW ASSAYS MARKET DURING THE FORECAST PERIOD. 91
8.2.1.3.5           SYPHILIS TESTING
8.2.1.3.5.1        THE GROWING ADOPTION OF NOVEL TECHNOLOGIES SUPPORTING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET FOR SYPHILIS TESTING
8.2.1.3.6           OTHER SEXUALLY TRANSMITTED INFECTION TESTING
8.2.1.4           HEPATITIS
8.2.1.4.1           NUCLEIC ACID HYBRIDIZATION-BASED LATERAL FLOW ASSAYS HOLD GREAT POTENTIAL IN HEPATITIS TESTING MARKET
8.2.1.5           TUBERCULOSIS
8.2.1.5.1           RISING PREVALENCE OF THE DISEASE AND A GROWING FOCUS ON EARLY DIAGNOSIS AND TREATMENT OF TUBERCULOSIS IS EXPECTED TO DRIVE THIS MARKET
8.2.1.6           OTHER INFECTIOUS DISEASE TESTS
8.2.2             CARDIAC MARKER TESTING
8.2.2.1           TROPONIN I AND T TESTING
8.2.2.1.1           INTRODUCTION OF HIGH-SENSITIVITY TROPONIN ASSAYS IS EXPECTED TO DRIVE THIS MARKET DURING THE FORECAST PERIOD
8.2.2.2           CK-MB TESTING
8.2.2.2.1           GROWING APPLICATION OF LATERAL FLOW TESTS IN ACUTE MYOCARDIAL INJURIES IS EXPECTED TO DRIVE THIS MARKET
8.2.2.3           BNP AND NT-PROBNP TESTING
8.2.2.3.1           INCREASING DEMAND FOR CARDIAC BIOMARKER TESTS TO DETECT HEART STRESS AND DAMAGE TO DRIVE THE GROWTH IN THIS MARKET
8.2.2.4           MYOGLOBIN TESTING
8.2.2.4.1           AVAILABILITY OF NEW HIGH-SENSITIVITY CARDIAC TROPONIN ASSAYS TO RESTRICT THE GROWTH OF THE ROUTINE MYOGLOBIN TESTING MARKET
8.2.2.5           D-DIMER TESTING
8.2.2.5.1           THE RISING INCIDENCE OF CARDIOVASCULAR DISEASES GLOBALLY IS EXPECTED TO DRIVE THE MARKET FOR D-DIMER TESTS
8.2.2.6           OTHER CARDIAC MARKER TESTS
8.2.3             PREGNANCY & FERTILITY TESTING
8.2.3.1           PREGNANCY TESTING
8.2.3.1.1           PREGNANCY TESTING IS AMONG WELL-ESTABLISHED APPLICATION AREAS FOR LATERAL FLOW ASSAYS, REGISTERING SLOWER GROWTH DURING THE FORECAST PERIOD
8.2.3.2           FERTILITY TESTING
8.2.3.2.1           RISING INFERTILITY RATES ACROSS THE GLOBE DRIVING THE DEMAND FOR POC FERTILITY TESTING KITS.
8.2.4             CHOLESTEROL TESTING/LIPID PROFILE
8.2.4.1           THE GROWING PREVALENCE OF OBESITY AND CVD IS THE KEY FACTOR DRIVING MARKET GROWTH
8.2.5             DRUGS OF ABUSE TESTING
8.2.5.1           TECHNOLOGICAL ADVANCEMENTS, RISING PUBLIC AWARENESS, AND GROWING FOCUS ON WORKPLACE DRUG TESTING IS DRIVING THE DRUGS OF ABUSE TESTING MARKET
8.2.6             OTHER CLINICAL TESTS MARKET
8.3            VETERINARY DIAGNOSTICS
8.3.1             INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) IS DRIVING THE DEMAND FOR  LATERAL FLOW TESTS
8.4            FOOD SAFETY & ENVIRONMENT TESTING
8.4.1             HIGH SENSITIVITY AND EASE OF USE DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING

8.5            DRUG DEVELOPMENT & QUALITY TESTING
8.5.1             INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE IS DRIVING THE GROWTH OF THIS MARKET. 116

9.... LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE

9.1            INTRODUCTION
9.2            SANDWICH ASSAYS
9.2.1             WIDE APPLICATIONS OF SANDWICH ASSAYS IN CLINICAL TESTING CONTRIBUTING TO THE LARGEST SHARE OF THIS SEGMENT
9.3            COMPETITIVE ASSAYS
9.3.1             HORMONE TESTING, DRUG TESTING, AND DRUGS OF ABUSE TESTING ARE PRIMARY APPLICATION AREAS OF COMPETITIVE ASSAYS
9.4            MULTIPLEX DETECTION ASSAYS
9.4.1             INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE THE GROWTH OF THIS MARKET

10.. LATERAL FLOW ASSAYS MARKET, BY END USER

10.1          INTRODUCTION
10.2          HOSPITALS & CLINICS
10.2.1           INCREASING USE OF POC TESTS AND FASTER DIAGNOSIS DRIVING ADOPTION OF LATERAL FLOW ASSAYS AMONG HOSPITALS & CLINICS
10.3          DIAGNOSTIC LABORATORIES
10.3.1           LABORATORY TESTING IS LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING
10.4          HOME CARE
10.4.1           GROWING ACCEPTANCE OF HOME AND REMOTE MONITORING DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET FOR HOME CARE
10.5          PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.5.1           INCREASING FOCUS ON PRODUCT SAFETY EXPECTED TO DRIVE THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET AMONG PHARMACEUTICAL AND BIOTECH COMPANIES
10.6          OTHERS END USERS

11.. LATERAL FLOW ASSAYS MARKET, BY REGION

11.1          INTRODUCTION
11.2          NORTH AMERICA
11.2.1           US
11.2.1.1         THE US ACCOUNTS FOR THE LARGEST SHARE OF THE GLOBAL LATERAL FLOW ASSAYS MARKET
11.2.2           CANADA
11.2.2.1         THE AVAILABILITY OF RESEARCH FUNDING AND IMPLEMENTATION OF FAVORABLE GOVERNMENT INITIATIVES IS DRIVING THE MARKET IN CANADA
11.3          EUROPE
11.3.1           GERMANY
11.3.1.1         ALONG WITH HOME CARE, GROWING NUMBER OF THE POC DIAGNOSTICS CENTERS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS IN GERMANY
11.3.2           FRANCE
11.3.2.1         PREVALENCE OF AGE-RELATED CHRONIC DISEASES AND INFECTIOUS DISEASES IS EXPECTED TO DRIVE THE MARKET GROWTH IN FRANCE
11.3.3           UK
11.3.3.1         INCREASING INCIDENCE OF CHRONIC DISEASES AND RISING PREVALENCE OF OBESITY PROPELLING THE MARKET GROWTH IN THE UK
11.3.4           ITALY
11.3.4.1         GROWING INITIATIVES TOWARDS DECENTRALIZATION OF MEDICAL SERVICES IN ITALY IS CONTRIBUTING TO THE MARKET GROWTH IN THE COUNTRY
11.3.5           SPAIN
11.3.5.1         INCREASING FOCUS OF INTERNATIONAL ORGANIZATIONS AND DOMESTIC PLAYERS TOWARD THE DEVELOPMENT OF POC PRODUCTS IN THE COUNTRY
11.3.6           REST OF EUROPE
11.4          ASIA PACIFIC
11.4.1           CHINA
11.4.1.1         ALONG WITH CLINICAL DIAGNOSTICS, THE GROWING ADOPTION OF LATERAL FLOW ASSAYS IN VETERINARY DIAGNOSTICS AND DRUG DEVELOPMENT EXPECTED TO DRIVE THE MARKET GROWTH IN CHINA
11.4.2           JAPAN
11.4.2.1         INCREASING PREVALENCE OF AGE-RELATED ILLNESSES, ATTRIBUTED TO THE GROWTH IN COUNTRY’S GERIATRIC POPULATION DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET IN JAPAN
11.4.3           INDIA
11.4.3.1         INCREASING PREVALENCE OF CHRONIC DISORDERS, GROWING HEALTHCARE CONCERNS, AND RISING INCOME LEVELS IS EXPECTED TO PROPEL THE GROWTH OF THIS MARKET. 202
11.4.4           REST OF ASIA PACIFIC
11.5          LATIN AMERICA
11.5.1           INCREASING INCIDENCE OF CHRONIC DISEASES DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS IN LATIN AMERICA
11.6          MIDDLE EAST & AFRICA
11.6.1           SIGNIFICANT SUPPORT FROM THE GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANSION OF HEALTHCARE SERVICES IS DRIVING ADOPTION OF LATERAL FLOW ASSAYS IN THE AFRICAN REGION

12.. COMPETITIVE LANDSCAPE

12.1          INTRODUCTION
12.2          PRODUCT PORTFOLIO ANALYSIS
12.3          GEOGRAPHICAL ASSESSMENT OF MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET
12.4          MARKET SHARE ANALYSIS (2017)
12.5          COMPETITIVE SITUATIONS AND TRENDS
12.5.1           PRODUCT LAUNCHES
12.5.2           ACQUISITIONS
12.5.3           AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
12.5.4           EXPANSIONS
12.6          COMPETITIVE ASSESSMENT OF R&D EXPENDITURE

13.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, SWOT ANALYSIS, MNM VIEW)*
13.1          ABBOTT LABORATORIES
13.2          F. HOFFMANN-LA ROCHE AG
13.3          DANAHER CORPORATION
13.4          SIEMENS AG
13.5          BECTON, DICKINSON AND COMPANY
13.6          BIOMÉRIEUX SA
13.7          BIO-RAD LABORATORIES, INC.
13.8          THERMO FISHER SCIENTIFIC INC.
13.9          QIAGEN N.V.
13.10        PERKINELMER INC.
13.11        HOLOGIC INC.
13.12        QUIDEL CORPORATION
13.13        MERCK KGAA
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, SWOT ANALYSIS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
14.. APPENDIX

LIST OF TABLES

TABLE 1              STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
TABLE 2              PREVALENCE OF HIV WORLDWIDE (2016-2017)
TABLE 3              REGULATORY STANDARD/APPROVAL REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION
TABLE 4              LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 5              LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 
2016–2023 (USD MILLION)
TABLE 6              LATERAL FLOW READERS IN THE MARKET
TABLE 7              LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 8              LATERAL FLOW READERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 9              DIGITAL/MOBILE READERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 10            BENCHTOP READERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 11            LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 12            LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 13            LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 
2016–2023 (USD MILLION)
TABLE 14            INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 15            INFECTIOUS DISEASE TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 16            MAJOR PRODUCTS: DENGUE TESTING
TABLE 17            MOSQUITO-BORNE DISEASE TESTING MARKET, BY COUNTRY,
2016–2023 (USD MILLION)
TABLE 18            INFLUENZA TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 19            SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 20            SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY COUNTRY, 
2016–2023 (USD MILLION)
TABLE 21            HIV TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 22            HPV TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 23            INCIDENCE OF CHLAMYDIA, BY COUNTRY, 2010–2016 (‘000)
TABLE 24            CHLAMYDIA TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 25            GONORRHEA TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 26            INCIDENCE OF SYPHILIS, BY COUNTRY, 2010–2016
TABLE 27            SYPHILIS TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 28            OTHER SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY COUNTRY,  2016–2023 (USD MILLION)
TABLE 29            HEPATITIS TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 30            TUBERCULOSIS TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 31            OTHER INFECTIOUS DISEASE TESTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION)
TABLE 32            CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 33            CARDIAC MARKER TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 34            TROPONIN I AND T TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 35            CK-MB TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 36            BNP & NT-PROBNP TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 37            MYOGLOBIN TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 38            D-DIMER TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 39            OTHER CARDIAC MARKER TESTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION)
TABLE 40            PREGNANCY & FERTILITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 41            PREGNANCY & FERTILITY TESTING MARKET, BY COUNTRY,
2016–2023 (USD MILLION)
TABLE 42            PREGNANCY TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 43            FERTILITY TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 44            CHOLESTEROL TESTING/LIPID PROFILE MARKET, BY COUNTRY, 
2016–2023 (USD MILLION)
TABLE 45            DRUGS OF ABUSE TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 46            OTHER CLINICAL TESTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 47            LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS,
BY COUNTRY,  2016–2023 (USD MILLION)
TABLE 48            LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING,  BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 49            LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING,  BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 50            LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
TABLE 51            LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY,
2016–2023 (USD MILLION)
TABLE 52            LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY,
2016–2023 (USD MILLION)
TABLE 53            LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 
2016–2023 (USD MILLION)
TABLE 54            LATERAL FLOW ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 55            LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 
2016–2023 (USD MILLION)
TABLE 56            LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES,
BY COUNTRY,  2016–2023 (USD MILLION)
TABLE 57            LATERAL FLOW ASSAYS MARKET FOR HOME CARE, BY COUNTRY, 
2016–2023 (USD MILLION)
TABLE 58            LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 59            LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 
2016–2023 (USD MILLION)
TABLE 60            LATERAL FLOW ASSAYS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 61            NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 62            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 
2016–2023 (USD MILLION)
TABLE 63            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 
2016–2023 (USD MILLION)
TABLE 64            NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 65            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 
2016–2023 (USD MILLION)
TABLE 66            NORTH AMERICA: CLINICAL TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 67            NORTH AMERICA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 68            NORTH AMERICA: SEXUALLY TRANSMITTED INFECTION TESTING MARKET,
BY TYPE,  2016–2023 (USD MILLION)
TABLE 69            NORTH AMERICA: CARDIAC MARKER TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 70            NORTH AMERICA: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 71            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 
2016–2023 (USD MILLION)
TABLE 72            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 
2016–2023 (USD MILLION)
TABLE 73            US: MACROECONOMIC INDICATORS
TABLE 74            US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 75            US: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 76            US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION)
TABLE 77            US: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 78            US: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 79            US: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 80            US: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 81            US: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 82            US: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
TABLE 83            US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 84            CANADA: MACROECONOMIC INDICATORS
TABLE 85            CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION)
TABLE 86            CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 87            CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION)
TABLE 88            CANADA: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 89            CANADA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 90            CANADA: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 91            CANADA: CARDIAC MARKER TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 92            CANADA: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 93            CANADA: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION)
TABLE 94            CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION)
TABLE 95            EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,
2016–2023 (USD MILLION)
TABLE 96            EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION)
TABLE 97            EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 98            EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION)
TABLE 99            EUROPE: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 100          EUROPE: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 101          EUROPE: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 102          EUROPE: CARDIAC MARKER TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 103          EUROPE: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 104          EUROPE: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION)
TABLE 105          EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION)
TABLE 106          GERMANY: MACROECONOMIC INDICATORS
TABLE 107          GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION)
TABLE 108          GERMANY: LATERAL FLOW READERS MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 109          GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 
2016–2023 (USD MILLION)
TABLE 110          GERMANY: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 111          GERMANY: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 112          GERMANY: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,  2016–2023 (USD MILLION)
TABLE 113          GERMANY: CARDIAC MARKER TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 114          GERMANY: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 115          GERMANY: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION)
TABLE 116          GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION)
TABLE 117          FRANCE: MACROECONOMIC INDICATORS
TABLE 118          FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION)
TABLE 119          FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 120          FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION)
TABLE 121          FRANCE: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 122          FRANCE: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 123          FRANCE: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)

TABLE 124          FRANCE: CARDIAC MARKER TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 125          FRANCE: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 126          FRANCE: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION)
TABLE 127          FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION)
TABLE 128          UK: MACROECONOMIC INDICATORS
TABLE 129          UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 130          UK: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 131          UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION)
TABLE 132          UK: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 133          UK: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 134          UK: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 135          UK: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 136          UK: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 137          UK: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION)
TABLE 138          UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 139          ITALY: MACROECONOMIC INDICATORS
TABLE 140          ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 141          ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 142          ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION)
TABLE 143          ITALY: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 144          ITALY: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 145          ITALY: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 146          ITALY: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 147          ITALY: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 148          ITALY: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION)
TABLE 149          ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION)
TABLE 150          SPAIN: MACROECONOMIC INDICATORS
TABLE 151          SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION)
TABLE 152          SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 153          SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION)
TABLE 154          SPAIN: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 155          SPAIN: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 156          SPAIN: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 157          SPAIN: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 158          SPAIN: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 159          SPAIN: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION)
TABLE 160          SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION)
TABLE 161          ROE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 162          ROE: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 163          ROE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION)
TABLE 164          ROE: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 165          ROE: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 166          ROE: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 167          ROE: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 168          ROE: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 169          ROE: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION)
TABLE 170          ROE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 171          APAC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 172          APAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 173          APAC: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 174          APAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION)
TABLE 175          APAC: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 176          APAC: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 177          APAC: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 178          APAC: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 179          APAC: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 180          APAC: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION)
TABLE 181          APAC: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION)
TABLE 182          CHINA: MACROECONOMIC INDICATORS
TABLE 183          CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION)
TABLE 184          CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 185          CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION)
TABLE 186          CHINA: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 187          CHINA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 188          CHINA: SEXUALLY TRANSMITTED INFECTION TESTING MARKET,
BY TYPE,  2016–2023 (USD MILLION)
TABLE 189          CHINA: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 190          CHINA: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 191          CHINA: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION)
TABLE 192          CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION)
TABLE 193          JAPAN: MACROECONOMIC INDICATORS
TABLE 194          JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION)
TABLE 195          JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 196          JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION)
TABLE 197          JAPAN: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 198          JAPAN: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 199          JAPAN: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 200          JAPAN: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 201          JAPAN: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 202          JAPAN: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION)
TABLE 203          JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION)
TABLE 204          INDIA: MACROECONOMIC INDICATORS
TABLE 205          INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 206          INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 207          INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION)
TABLE 208          INDIA: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 209          INDIA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 210          INDIA: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 211          INDIA: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 212          INDIA: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 213          INDIA: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION)
TABLE 214          INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION)
TABLE 215          ROAPAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION)
TABLE 216          ROAPAC: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 217          ROAPAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION)
TABLE 218          ROAPAC: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 219          ROAPAC: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 220          ROAPAC: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 221          ROAPAC: CARDIAC MARKER TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 222          ROAPAC: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 223          ROAPAC: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION)
TABLE 224          ROAPAC: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION)
TABLE 225          BRAZIL: MACROECONOMIC INDICATORS
TABLE 226          LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 
2016–2023 (USD MILLION)
TABLE 227          LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 228          LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 
2016–2023 (USD MILLION)
TABLE 229          LATIN AMERICA: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 230          LATIN AMERICA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 231          LATIN AMERICA: SEXUALLY TRANSMITTED INFECTION TESTING MARKET,
BY TYPE, 2016–2023 (USD MILLION)
TABLE 232          LATIN AMERICA: CARDIAC MARKER TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 233          LATIN AMERICA: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 234          LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 
2016–2023 (USD MILLION)
TABLE 235          LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 
2016–2023 (USD MILLION)
TABLE 236          MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 
2016–2023 (USD MILLION)
TABLE 237          MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 238          MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 239          MIDDLE EAST & AFRICA: CLINICAL TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 240          MIDDLE EAST & AFRICA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 241          MIDDLE EAST & AFRICA: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 242          MIDDLE EAST & AFRICA: CARDIAC MARKER TESTING MARKET, BY TYPE, 
2016–2023 (USD MILLION)
TABLE 243          MIDDLE EAST & AFRICA: PREGNANCY & FERTILITY TESTING MARKET,
BY TYPE,  2016–2023 (USD MILLION)
TABLE 244          MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 
2016–2023 (USD MILLION)
TABLE 245          MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 
2016–2023 (USD MILLION)
TABLE 246          PRODUCT LAUNCHES (2018)
TABLE 247          ACQUISITIONS (2017-2018)
TABLE 248          COLLABORATIONS, AGREEMENT, AND PARTNERSHIPS (2017-2018)
TABLE 249          EXPANSIONS (2016-2017)

LIST OF FIGURES

FIGURE 1            LATERAL FLOW ASSAYS MARKET
FIGURE 2            RESEARCH DESIGN
FIGURE 3            PRIMARY SOURCES
FIGURE 4            BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATIONS, AND REGION
FIGURE 5            BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATIONS, AND REGION
FIGURE 6            DATA TRIANGULATION METHODOLOGY
FIGURE 7            LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
FIGURE 8            LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,  2018 VS. 2023 (USD MILLION)
FIGURE 9            LATERAL FLOW ASSAYS MARKET, BY APPLICATION,  2018 VS. 2023 (USD MILLION)
FIGURE 10          LATERAL FLOW ASSAYS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
FIGURE 11          GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAYS MARKET
FIGURE 12          RAPID GROWTH IN THE GERIATRIC POPULATION–KEY FACTOR
DRIVING MARKET GROWTH FOR LATERAL FLOW ASSAYS
FIGURE 13          DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING 
THE FORECAST PERIOD
FIGURE 14          CHINA TO GROW AT THE FASTEST RATE DURING FORECAST PERIOD
FIGURE 15          NORTH AMERICA WILL CONTINUE TO DOMINATE THE LATERAL FLOW ASSAYS MARKET THROUGH 2023
FIGURE 16          CLINICAL TESTING SEGMENT AND CHINA COMMANDED THE LARGEST SHARE OF THE ASIA PACIFIC LATERAL FLOW ASSAYS MARKET IN 2017
FIGURE 17          PREVALENCE OF INFECTIOUS DISEASES WORLDWIDE
FIGURE 18          GLOBAL GERIATRIC POPULATION, BY REGION, 2010 VS. 2015 VS. 2030
FIGURE 19          ELDERLY POPULATION, BY COUNTRY, 2010 VS. 2017 (MILLION)
FIGURE 20          LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2017)
FIGURE 21          LATERAL FLOW ASSAYS MARKET: SUPPLY CHAIN ANALYSIS (2017)
FIGURE 22          MICROFLUIDICS MARKET TO REGISTER THE HIGHEST CAGR FROM  2018 TO 2023
FIGURE 23          IN VITRO DIAGNOSTICS: MARKET SNAPSHOT
FIGURE 24          POINT-OF-CARE DIAGNOSTICS: MARKET SNAPSHOT
FIGURE 25          MICROFLUIDICS MARKET: MARKET SNAPSHOT
FIGURE 26          CAPILLARY ELECTROPHORESIS SYSTEMS: MARKET SNAPSHOT
FIGURE 27          KITS & REAGENTS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL LATERAL FLOW ASSAYS MARKET IN 2023
FIGURE 28          CLINICAL TESTING SEGMENT TO DOMINATE THE LATERAL FLOW ASSAYS MARKET, BY APPLICATION, DURING THE FORECAST PERIOD
FIGURE 29          PATIENTS BEING TREATED FOR HIV GLOBALLY, 2000–2015
FIGURE 30          SANDWICH ASSAYS TO DOMINATE THE LATERAL FLOW ASSAYS MARKET DURING THE FORECAST PERIOD
FIGURE 31          HOSPITALS & CLINICS TO DOMINATE THE LATERAL FLOW ASSAYS MARKET DURING THE FORECAST PERIOD
FIGURE 32          NORTH AMERICA TO DOMINATE THE MARKET DURING FORECAST PERIOD
FIGURE 33          CHINA TO GROW AT THE FASTEST RATE DURING THE FORECAST PERIOD
FIGURE 34          NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
FIGURE 35          EUROPE: LATERAL FLOW ASSAYS MARKET SNAPSHOT
FIGURE 36          ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT
FIGURE 37          KEY DEVELOPMENTS IN THE LATERAL FLOW ASSAYS MARKET BETWEEN 
2015 AND 2018
FIGURE 38          LATERAL FLOW ASSAY PRODUCT PORTFOLIO MATRIX
FIGURE 39          GEOGRAPHICAL REVENUE MIX: LATERAL FLOW ASSAYS MARKET (2017)
FIGURE 40          LATERAL FLOW ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER (2017)
FIGURE 41          R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET 2015 & 2017
FIGURE 42          ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017)
FIGURE 43          F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2017)
FIGURE 44          DANAHER CORPORATION: COMPANY SNAPSHOT (2017)
FIGURE 45          SIEMENS AG: COMPANY SNAPSHOT (2017)
FIGURE 46          BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017)
FIGURE 47          BIOMÉRIEUX SA: COMPANY SNAPSHOT (2017)
FIGURE 48          BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2017)
FIGURE 49          THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2017)
FIGURE 50          QIAGEN N.V.: COMPANY SNAPSHOT (2017)
FIGURE 51          PERKINELMER INC.: COMPANY SNAPSHOT (2017)
FIGURE 52          HOLOGIC, INC.: COMPANY SNAPSHOT (2017)
FIGURE 53          QUIDEL CORPORATION: COMPANY SNAPSHOT (2017)
FIGURE 54          MERCK KGAA: COMPANY SNAPSHOT (2017)
FIGURE 55          KNOWLEDGE STORE SNAPSHOT
FIGURE 56          MARKETSANDMARKETS KNOWLEDGE STORE: HEALTHCARE INDUSTRY SNAPSHOT

当レポートのプレスリリースは発行されておりません。